IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 34.667

Change

+0.20 (+0.58)%

Market Cap

N/A

Volume

24.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.35 (-1.70%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.11 (-0.18%)

USD 36.47B
DFAC Dimensional U.S. Core Equity 2..

-0.19 (-0.53%)

USD 31.32B
JPST JPMorgan Ultra-Short Income ET..

-0.02 (-0.04%)

USD 26.94B
SGOV iShares® 0-3 Month Treasury B..

+0.01 (+0.01%)

USD 26.72B
DTB DTE Energy Company 2020 Series

-0.19 (-0.94%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

+2.01 (+2.90%)

USD 15.23B
AVUV Avantis® U.S. Small Cap Value..

-1.38 (-1.32%)

USD 14.03B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 13.91B
CGDV Capital Group Dividend Value E..

-0.33 (-0.89%)

USD 11.53B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.12% 61% D- 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.12% 60% D- 58% F
Trailing 12 Months  
Capital Gain 34.35% 78% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.35% 78% C+ 70% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.11% 75% C 56% F
Dividend Return 6.44% 73% C 50% F
Total Return 0.32% 20% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 8.82% 56% F 82% B
Risk Adjusted Return 72.99% 80% B- 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.